UK Could Block Activist Plans To Shake Up GSK

New Law Allows Intervention

GlaxoSmithKline is under attack from an activist investor, but as a key UK company, the government could use new powers to block any deals “not in the national interest”.

GSK_HQ

The UK government is worried about a bid by an activist investor to shake up GlaxoSmithKline, and could make use of new powers to protect companies that are seen as vital to the nation’s interests.

Alongside AstraZenenca, GSK is one of UK’s two big pharma companies, employing 13,000 people in the country and investing around...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip